Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1968 May;44(511):385–397. doi: 10.1136/pgmj.44.511.385

Thyrotoxic muscle disease

Ian Ramsay
PMCID: PMC2466597  PMID: 4871773

Abstract

Evidence suggests that most hyperthyroid patients have a proximal myopathy. The more severe this is the more frequently are distal muscles, and ultimately, bulbar muscles involved. Probably acute thyrotoxic myopathy or encephalopathy supervenes on a previous chronic background or occurs concurrently with skeletal muscle involvement. Using careful electromyographic techniques evidence of myopathy may be found in most thyrotoxics; it disappears with adequate treatment of the primary disease.

Myasthenia gravis and periodic paralysis are also associated with thyrotoxicosis and their differentiation is discussed. Infiltrative ophthalmopathy is not related to the effects of excess thyroid hormone, but is possibly due to EPS working in conjunction with LATS.

Full text

PDF
389

Images in this article

394Fig. 2
on p.394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON J. R., GRAY K. G., MIDDLETON D. G., YOUNG J. A. AUTOIMMUNITY AND THYROTOXICOSIS. Br Med J. 1964 Dec 26;2(5425):1630–1632. doi: 10.1136/bmj.2.5425.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ASBOE-HANSEN G., IVERSEN K. Influence of thyrotrophic hormone on connective tissue; pathogenetic significance of mucopolysaccharides in experimental exophthalmos. Acta Endocrinol (Copenh) 1951;8(1):90–96. doi: 10.1530/acta.0.0080090. [DOI] [PubMed] [Google Scholar]
  3. ASBOE-HANSEN G., IVERSEN K., WICHMANN R. Malignant exophthalmos; muscular changes and thyrotrophin content in serum. Acta Endocrinol (Copenh) 1952 Dec;11(4):376–399. [PubMed] [Google Scholar]
  4. ASBOE-HANSEN G., IVERSEN K., WICHMANN R. Progressiv exophthalmus, muskelforandringer og serumthyreotopin. Ugeskr Laeger. 1953 Jun 4;115(23):889–895. [PubMed] [Google Scholar]
  5. ASKONAS B. A. Effect of thyroxine on creatinephosphokinase activity. Nature. 1951 Jun 9;167(4258):933–934. doi: 10.1038/167933a0. [DOI] [PubMed] [Google Scholar]
  6. BOSTROM H., HED R. Thyrotoxic myopathy and polymyositis in elderly patients; differential-diagnostic viewpoints. Acta Med Scand. 1958 Oct 22;162(3):225–230. doi: 10.1111/j.0954-6820.1958.tb01768.x. [DOI] [PubMed] [Google Scholar]
  7. BRAIN R. Pathogenesis and treatment of endocrine exophthalmos. Lancet. 1959 Jan 17;1(7064):109–115. doi: 10.1016/s0140-6736(59)90001-7. [DOI] [PubMed] [Google Scholar]
  8. BUCHTHAL F., GULD C., ROSENFALCK P. Propagation velocity in electrically activated muscle fibres in man. Acta Physiol Scand. 1955 Sep 20;34(1):75–89. doi: 10.1111/j.1748-1716.1955.tb01227.x. [DOI] [PubMed] [Google Scholar]
  9. Blizzard R. M., Chee D., Davis W. The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison's disease). Clin Exp Immunol. 1967 Jan;2(1):19–30. [PMC free article] [PubMed] [Google Scholar]
  10. Brodie B. B., Davies J. I., Hynie S., Krishna G., Weiss B. Interrelationships of catecholamines with other endocrine systems. Pharmacol Rev. 1966 Mar;18(1):273–289. [PubMed] [Google Scholar]
  11. CASTLEMAN B., NORRIS E. H. The pathology of the thymus in myasthenia gravis; a study of 35 cases. Medicine (Baltimore) 1949 Feb;28(1):27–58. doi: 10.1097/00005792-194902000-00002. [DOI] [PubMed] [Google Scholar]
  12. CHAPMAN E. M., MALOOF F. Bizarre clinical manifestations of hyperthyroidism. N Engl J Med. 1956 Jan 5;254(1):1–5. doi: 10.1056/NEJM195601052540101. [DOI] [PubMed] [Google Scholar]
  13. COLLINGS H., Jr, LIENHARD W. F., Jr Thyrotoxic myopathy with disturbance of potassium metabolism. Neurology. 1957 Sep;7(9):667–669. doi: 10.1212/wnl.7.9.667. [DOI] [PubMed] [Google Scholar]
  14. COOMES E. N. THE RATE OF RECOVERY OF REVERSIBLE MYOPATHIES AND THE EFFECTS OF ANABOLIC AGENTS IN STEROID MYOPATHY. Neurology. 1965 Jun;15:523–530. doi: 10.1212/wnl.15.6.523. [DOI] [PubMed] [Google Scholar]
  15. DOBYNS B. M. Present concepts of the pathologic physiology of exophthalmos. J Clin Endocrinol Metab. 1950 Oct;10(10):1202–1230. doi: 10.1210/jcem-10-10-1202. [DOI] [PubMed] [Google Scholar]
  16. DOBYNS B. M., WRIGHT A., WILSON L. Assay of the exophthalmos-producing substance in the serum of patients with progressive exophthalmos. J Clin Endocrinol Metab. 1961 Jun;21:648–662. doi: 10.1210/jcem-21-6-648. [DOI] [PubMed] [Google Scholar]
  17. EALES L., HOFFENBERG R. Chronic thyrotoxic myopathy; a report of two cases. S Afr Med J. 1956 Dec 29;30(52):1246–1249. [PubMed] [Google Scholar]
  18. ENGEL A. G. Thyroid function and myasthenia gravis. Arch Neurol. 1961 Jun;4:663–674. doi: 10.1001/archneur.1961.00450120077009. [DOI] [PubMed] [Google Scholar]
  19. ENGEL A. G. Thyroid function and periodic paralysis. Am J Med. 1961 Feb;30:327–333. doi: 10.1016/0002-9343(61)90104-8. [DOI] [PubMed] [Google Scholar]
  20. Engel A. G. Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies. Mayo Clin Proc. 1966 Nov;41(11):785–796. [PubMed] [Google Scholar]
  21. GIMLETTE T. M. The muscular lesion in hyperthyroidism. Br Med J. 1959 Nov 28;2(5160):1143–1146. doi: 10.1136/bmj.2.5160.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. GREENE R. Thyrotoxicosis; exophthalmic ophthalmoplegia, myasthenia gravis and vitiligo. Proc R Soc Med. 1949 Apr;42(4):263–267. [PMC free article] [PubMed] [Google Scholar]
  23. GROB D., LILJESTRAND A., JOHNS R. J. Potassium movement in normal subjects: effect on muscle function. Am J Med. 1957 Sep;23(3):340–355. doi: 10.1016/0002-9343(57)90315-7. [DOI] [PubMed] [Google Scholar]
  24. GROB D. Metabolic diseases of muscle. Annu Rev Med. 1963;14:151–174. doi: 10.1146/annurev.me.14.020163.001055. [DOI] [PubMed] [Google Scholar]
  25. GROB D. Myasthenia gravis. A review of pathogenesis and treatment. Arch Intern Med. 1961 Oct;108:615–638. doi: 10.1001/archinte.1961.03620100107017. [DOI] [PubMed] [Google Scholar]
  26. HARMAN J. B., RICHARDSON A. T. Generalised myokymia in thyrotoxicosis report of a case. Lancet. 1954 Sep 4;267(6836):473–474. doi: 10.1016/s0140-6736(54)91880-2. [DOI] [PubMed] [Google Scholar]
  27. HAVARD C. W., CAMPBELL E. D., ROSS H. B., SPENCE A. W. Electromyographic and histological findings in the muscles of patients with thyrotoxicosis. Q J Med. 1963 Apr;32:145–163. [PubMed] [Google Scholar]
  28. HED R., KIRSTEIN L., LUNDMARK C. Thyrotoxic myopathy. J Neurol Neurosurg Psychiatry. 1958 Nov;21(4):270–278. doi: 10.1136/jnnp.21.4.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. HEINRICH W. D., McCABE E. B., NICELY D. A., ELDER J. C. Encephalopathic hyperthyroidism manifesting as dysphagia. Am J Roentgenol Radium Ther Nucl Med. 1962 Aug;88:336–338. [PubMed] [Google Scholar]
  30. HOCH F. L. Thyrotoxicosis as a disease of mitochondria. N Engl J Med. 1962 Mar 8;266:498–concl. doi: 10.1056/NEJM196203082661007. [DOI] [PubMed] [Google Scholar]
  31. HUXLEY A. F., TAYLOR R. E. Local activation of striated muscle fibres. J Physiol. 1958 Dec 30;144(3):426–441. doi: 10.1113/jphysiol.1958.sp006111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hoch F. L. Biochemistry of hyperthyroidism and hypothyroidism. Postgrad Med J. 1968 May;44(511):347–362. doi: 10.1136/pgmj.44.511.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. IVERSEN K., ASBOE-HANSEN G., CARLSEN F. Electron microscopy of certain muscle lesions in patients with pituitary-thyroid disorders. Acta Endocrinol (Copenh) 1953 Oct;14(2):177–180. doi: 10.1530/acta.0.0140177. [DOI] [PubMed] [Google Scholar]
  34. IVERSEN K., ASBOE-HANSEN G. Studies on the fat-mobilizing factor of the anterior pituitary gland; suppressive action of thyroxin. Acta Endocrinol (Copenh) 1952 Oct;11(2):111–118. doi: 10.1530/acta.0.0110111. [DOI] [PubMed] [Google Scholar]
  35. Irvine W. J., Stewart A. G., Scarth L. A clinical and immunological study of adrenocortical insufficiency (Addison's disease). Clin Exp Immunol. 1967 Jan;2(1):31–70. [PMC free article] [PubMed] [Google Scholar]
  36. KIRCHHEINER B. Specific muscle lesions in pituitary-thyroid disorders. Acta Med Scand. 1962 Nov;172:539–543. doi: 10.1111/j.0954-6820.1962.tb07190.x. [DOI] [PubMed] [Google Scholar]
  37. KITE W. C., Jr, McCLINTOCK J. C., GRAVES R. W. Chronic thyrotoxic myopathy. N Y State J Med. 1954 Jun 1;54(11):1613–1616. [PubMed] [Google Scholar]
  38. LOGOTHETIS J. Neurologic and muscular manifestations of hyperthyroidism. Arch Neurol. 1961 Nov;5:533–544. doi: 10.1001/archneur.1961.00450170071009. [DOI] [PubMed] [Google Scholar]
  39. LUDWIG A. W., BOAS N. F., SOFFER L. J. Role of mucopolysaccharides in pathogenesis of experimental exophthalmos. Proc Soc Exp Biol Med. 1950 Jan;73(1):137-40, illust. doi: 10.3181/00379727-73-17604. [DOI] [PubMed] [Google Scholar]
  40. MACLEAN B., WILSON J. A. See-saw relationship between hyperthyroidism and myasthenia gravis. Lancet. 1954 May 8;266(6819):950–953. doi: 10.1016/s0140-6736(54)91566-4. [DOI] [PubMed] [Google Scholar]
  41. MELVILLE I. D. Chronic thyrotoxic myopathy. Scott Med J. 1959 Jun;4(6):318–323. doi: 10.1177/003693305900400606. [DOI] [PubMed] [Google Scholar]
  42. MILLIKAN C. H., HAINES S. F. The thyroid gland in relation to neuromuscular disease. AMA Arch Intern Med. 1953 Jul;92(1):5–39. doi: 10.1001/archinte.1953.00240190017002. [DOI] [PubMed] [Google Scholar]
  43. McCULLAGH E. P., CLAMEN M., GARDNER W. J. Clinical progress in the treatment of exophthalmos of Graves' disease, with particular reference to the effect of pituitary surgery. J Clin Endocrinol Metab. 1957 Nov;17(11):1277–1292. doi: 10.1210/jcem-17-11-1277. [DOI] [PubMed] [Google Scholar]
  44. McCool J. L., Naffziger H. C. The Pathologic Changes in the Orbit in Progressive Exophthalmos, with Special Reference to Alterations in the Extra-Ocular Muscles and the Optic Discs. Trans Am Ophthalmol Soc. 1932;30:103–124. [PMC free article] [PubMed] [Google Scholar]
  45. OKINAKA S., SHIZUME K., IINO S., WATANABE A., IRIE M., NOGUCHI A., KUMA S., KUMA K., ITO T. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab. 1957 Dec;17(12):1454–1459. doi: 10.1210/jcem-17-12-1454. [DOI] [PubMed] [Google Scholar]
  46. PIMSTONE B. L., HOFFENBERG R., BLACK E. PARALLEL ASSAYS OF THYROTROPHIN, LONG-ACTING THYROID STIMULATOR AND EXOPHTHALMOS-PRODUCING SUBSTANCE IN ENDOCRINE EXOPHTHALMOS AND PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab. 1964 Oct;24:976–982. doi: 10.1210/jcem-24-10-976. [DOI] [PubMed] [Google Scholar]
  47. PIPBERGER H., KALIN R., WEGMANN T. Muskuläre Störungen bei der Hyperthyreose. Schweiz Med Wochenschr. 1955 Apr 23;85(17):390–393. [PubMed] [Google Scholar]
  48. Parsons V., Ramsay I. Thyroid and adrenal relationships. Postgrad Med J. 1968 May;44(511):377–384. doi: 10.1136/pgmj.44.511.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. QUINN E. L., WORCESTER R. L. Chronic thyrotoxic myopathy: report of a case. J Clin Endocrinol Metab. 1951 Dec;11(12):1564–1571. doi: 10.1210/jcem-11-12-1564. [DOI] [PubMed] [Google Scholar]
  50. ROWLAND L. P., ARANOW H., Jr, HOEFER P. F. Myasthenia gravis appearing after the removal of thymoma. Neurology. 1957 Aug;7(8):584–588. doi: 10.1212/wnl.7.8.584. [DOI] [PubMed] [Google Scholar]
  51. Ramsay I. D. Electromyography in thyrotoxicosis. Q J Med. 1965 Jul;34(135):255–267. [PubMed] [Google Scholar]
  52. Ramsay I. D. Muscle dysfunction in hyperthyroidism. Lancet. 1966 Oct 29;2(7470):931–934. doi: 10.1016/s0140-6736(66)90536-8. [DOI] [PubMed] [Google Scholar]
  53. SANDERSON K. V., ADEY W. R. Chronic thyreotoxic myopathy, with the report of a case including electromyographic studies. Med J Aust. 1949 Jun 18;1(25):797–804. doi: 10.5694/j.1326-5377.1949.tb68070.x. [DOI] [PubMed] [Google Scholar]
  54. SANDERSON K. V., ADEY W. R. Electromyographic and endocrine studies in chronic thyrotoxic myopathy. J Neurol Neurosurg Psychiatry. 1952 Aug;15(3):200–205. doi: 10.1136/jnnp.15.3.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. SATOYOSHI E., MURAKAMI K., KOWA H., KINOSHITA M., NOGUCHI K., HOSHINA S., NISHIYAMA Y., ITO K. MYOPATHY IN THYROTOXICOSIS. WITH SPECIAL EMPHASIS ON AN EFFECT OF POTASSIUM INGESTION ON SERUM AND URINARY CREATINE. Neurology. 1963 Aug;13:645–658. doi: 10.1212/wnl.13.8.645. [DOI] [PubMed] [Google Scholar]
  56. STAFFURTH J. S., THOMPSON J. C. MUSCLE POTASSIUM IN THYROTOXICOSIS. Metabolism. 1965 Mar;14:241–245. doi: 10.1016/0026-0495(65)90064-8. [DOI] [PubMed] [Google Scholar]
  57. STRONG J. A. Thyrotoxicosis, with ophthalmoplegia, myopathy, Wolff-Parkinson-White syndrome, and pericardial friction. Lancet. 1949 Jun 4;1(6562):959–961. doi: 10.1016/s0140-6736(49)92054-1. [DOI] [PubMed] [Google Scholar]
  58. Schwarz F., Kinderen PJ der, Houtstra-Lanz M. The correlation between endocrine exophthalmos and exophthalmos producing substance (EPS). Acta Endocrinol (Copenh) 1966 Mar;51(3):359–368. doi: 10.1530/acta.0.0510359. [DOI] [PubMed] [Google Scholar]
  59. Shishiba Y., Shizume K., Sakuma M., Yamauchi H., Nakao K., Okinaka S. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. 3. Intra- and extracellular concentrations of potassium and sodium in muscle and their changes during induced attacks of paralysis. Metabolism. 1966 Feb;15(2):153–162. doi: 10.1016/0026-0495(66)90037-0. [DOI] [PubMed] [Google Scholar]
  60. Shizume K., Shishiba Y., Sakuma M., Yamauchi H., Nakao K., Okinaka S. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. I. Arteriovenous differences of electrolytes during induced paralysis. Metabolism. 1966 Feb;15(2):138–144. doi: 10.1016/0026-0495(66)90035-7. [DOI] [PubMed] [Google Scholar]
  61. Simpson J. A. Myasthenia gravis as an autoimmune disease: clinical aspects. Ann N Y Acad Sci. 1966 Jan 26;135(1):506–516. doi: 10.1111/j.1749-6632.1966.tb45499.x. [DOI] [PubMed] [Google Scholar]
  62. TAPLEY D. F. MODE AND SITE OF ACTION OF THYROXINE. Mayo Clin Proc. 1964 Aug;39:626–636. [PubMed] [Google Scholar]
  63. WEGELIUS O., ASBOE-HANSEN G., LAMBERG B. A. Retrobulbar connective tissue changes in malignant exophthalmos. Acta Endocrinol (Copenh) 1957 Aug;25(4):452–456. doi: 10.1530/acta.0.0250452. [DOI] [PubMed] [Google Scholar]
  64. WHITFIELD A. G., HUDSON W. A. Chronic thyrotoxic myopathy. Q J Med. 1961 Jul;30:257–267. [PubMed] [Google Scholar]
  65. Wilkins L., Fleischmann W. EFFECTS OF THYROID ON CREATINE METABOLISM WITH A DISCUSSION OF THE MECHANISM OF STORAGE AND EXCRETION OF CREATINE BODIES. J Clin Invest. 1946 May;25(3):360–377. doi: 10.1172/JCI101717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. YATES D. A. ELECTRODIAGNOSIS OF MYOPATHIC DISORDERS. Postgrad Med J. 1965 Jun;41:325–331. doi: 10.1136/pgmj.41.476.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. YATES D. A. THE ESTIMATION OF MEAN POTENTIAL DURATION IN ENDOCRINE MYOPATHY. J Neurol Neurosurg Psychiatry. 1963 Oct;26:458–461. doi: 10.1136/jnnp.26.5.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. ZIERLER K. L. Muscular wasting of obscure origin and the thyroid gland. Bull Johns Hopkins Hosp. 1951 Oct;89(4):263–280. [PubMed] [Google Scholar]
  69. der KINDEREN P. J., HOUTSTRA-LANZ M., SCHWARZ F. Exophthalmos-producing substance in human serum. J Clin Endocrinol Metab. 1960 May;20:712–718. doi: 10.1210/jcem-20-5-712. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES